Wellington, CO, United States of America

Glenn R Frank

USPTO Granted Patents = 53 

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 280(Granted Patents)

Forward Citations (Not Self Cited) = 263(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Sherman, CT (US) (1994)
  • Fort Collins, CO (US) (1996 - 1998)
  • Ft. Collins, CO (US) (1997 - 2005)
  • Wellington, CO (US) (1997 - 2010)

Company Filing History:


Years Active: 1994-2010

Loading Chart...
Areas of Expertise:
Ectoparasite Saliva Proteins
Filariid Nematode Proteins
Parasitic Helminth Proteins
Antibody Response Elicitation
Nucleic Acid Molecules
Protease Inhibitors
Dirofilaria Detection
Flea Protease Proteins
Feline Fc Epsilon Receptor
Astacin Metalloendopeptidase Antibodies
Parasitic Nematode Vaccines
Cysteine Protease Genes
53 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Glenn R Frank in Veterinary Science

Introduction

Glenn R Frank, based in Wellington, Colorado, has made significant contributions to the field of veterinary science through his extensive work and innovative inventions. With an impressive total of 53 patents to his name, Frank has focused his research on methods related to animal health, specifically addressing allergies and ectoparasite-related issues.

Latest Patents

Among his latest patents is a groundbreaking method to detect IgE, which utilizes a human Fc epsilon receptor (FcR) to identify IgE antibodies in biological samples from animals such as cats, dogs, and horses. This innovative method also includes the development of corresponding kits to facilitate the detection process. Another notable patent involves nucleic acid molecules that encode a novel ectoparasite saliva protein. This invention not only offers methods for isolating ectoparasite saliva proteins but also provides solutions for detecting and treating allergic dermatitis in animals. Frank's work in this area includes a saliva protein collection apparatus designed to gather ectoparasite saliva proteins while minimizing contamination. His research has led to the creation of therapeutic compositions that utilize these proteins for treating animals affected by allergic reactions.

Career Highlights

Throughout his career, Glenn R Frank has collaborated with various organizations, including Heska Corporation and Colorado State University Research Foundation. His role in these institutions has advanced the study and treatment of animal allergies, contributing to the welfare of pets and livestock alike.

Collaborations

Frank's innovative work has been enhanced through collaborations with esteemed colleagues such as Robert B Grieve and Keith E Rushlow. These partnerships have fostered a dynamic exchange of ideas and expertise, further driving advancements in veterinary science.

Conclusion

Glenn R Frank stands out as a prominent figure in veterinary innovation, with a body of work that addresses critical health challenges in animals. His contributions not only demonstrate his commitment to improving animal health but also reflect the continual advancement of research and technology in the veterinary field. As he continues to develop new methods and solutions, Frank remains a vital asset to the scientific community and animal healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…